CORC  > 湖南大学
Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.
Zhang Xiaoning; Huai Yangyang; Cai Jing; Song Chuli; Zhang Yingjiu
刊名International immunopharmacology
2018
卷号Vol.67页码:176-185
关键词Aggregation Alzheimer's disease Amyloid-β Cytotoxicity scFv antibody
ISSN号1878-1705
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5462411
专题湖南大学
作者单位1.Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, Jilin University, Changchun, China. Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, Jilin University, Changchun, China
2.China-Japan Union Hospital of Jilin University, Changchun, China. Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, Jilin University, Changchun, China
3.School of Life Science, Jilin University, Changchun, China. Electronic address: yingjiu@jlu.edu.cn.
推荐引用方式
GB/T 7714
Zhang Xiaoning,Huai Yangyang,Cai Jing,et al. Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.[J]. International immunopharmacology,2018,Vol.67:176-185.
APA Zhang Xiaoning,Huai Yangyang,Cai Jing,Song Chuli,&Zhang Yingjiu.(2018).Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates..International immunopharmacology,Vol.67,176-185.
MLA Zhang Xiaoning,et al."Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.".International immunopharmacology Vol.67(2018):176-185.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace